Atg4D Antibodies

Santa Cruz Biotechnology provides a broad selection of Atg4D monoclonal antibodies for research in autophagy and cellular homeostasis. Atg4D monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Atg4D, a member of the autophagy-related protein family, plays a crucial role in the processing of LC3 and the regulation of autophagosome formation. The function of Atg4D is vital for maintaining cellular health and responding to stress, making it an important target for studies related to neurodegenerative diseases, cancer, and metabolic disorders. Understanding Atg4D in cellular processes can provide insights into potential therapeutic strategies. Researchers can explore the molecular mechanisms of autophagy through detailed characterization of Atg4D expression and activity. Current studies focusing on Atg4D continue to reveal new aspects of autophagy regulation and its impact on disease progression. Santa Cruz Biotechnology monoclonal antibodies for Atg4D support researchers worldwide in advancing scientific understanding of autophagy and its role in human health and disease.